These kits are manufactured in accordance with the 98/79 EC directive for in vitro diagnostic devices. Only CE marked products can be used for diagnostic applications in Europe.
These kits are intended for in vitro diagnostic use.
These kits are for research use only and are not intended to be used for diagnostic procedures.
Federal Drug Administration, FDA validates diagnostic kits for in vitro diagnostic use in the United States.
Biological risk products.
Storage between 2 and 8 ° C.
Reactive in liquid form.
Reactive in lyophilized form.
Reactive in frozen form.
Stability after opening at 2-8 ° C.
Products that can be refrozen.
Stability 12 months after refreezing at -20 ° C.
Application: Inhibitor of the activity of FVIIa, Wester Blot (in non-reduced condition) Host : Mouse Immunogen : Human purified FVIIa
The Safety Data Sheets and Notices are accessible to our registered customers.
Factor VII (FVII) is a glycoprotein synthesized by the liver, zymogen of a serine protease. It is a vitamin K dependent factor belonging to the prothrombin complex. Its half-life is 4 to 6 hours and it is the only coagulation factor present in trace amounts in its active form. When tissue factor appears on the endothelial surface, activated FVII associates with it initiating the extrinsic pathway for coagulation. This complex (FT-FVIIa) will activate the FX in FXa and the FIX in FIXa.
Antibody lyophilized in 400 μl of PBS and 100 mM mannitol, pH 7.4. To be reconstituted with 0.4mL of distilled water. After reconstitution stored at -20 ° C and avoid freeze / thaw cycles.
The lyophilized presentation allows greater stability until the expiration date.